IRIS
VELLA, VERONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.492
EU - Europa 1.626
AS - Asia 1.557
AF - Africa 304
SA - Sud America 281
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.391
SG - Singapore 707
IT - Italia 622
CN - Cina 529
IE - Irlanda 291
BR - Brasile 248
CI - Costa d'Avorio 209
UA - Ucraina 165
DE - Germania 125
BE - Belgio 107
VN - Vietnam 102
CA - Canada 80
NL - Olanda 80
GB - Regno Unito 67
RU - Federazione Russa 61
SN - Senegal 58
IN - India 55
KR - Corea 54
SE - Svezia 31
JP - Giappone 16
MX - Messico 16
AR - Argentina 15
TR - Turchia 15
PL - Polonia 13
CH - Svizzera 12
BD - Bangladesh 11
IR - Iran 11
FI - Finlandia 10
CZ - Repubblica Ceca 8
IQ - Iraq 8
NG - Nigeria 8
UZ - Uzbekistan 8
EC - Ecuador 7
FR - Francia 7
HK - Hong Kong 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
ES - Italia 6
BJ - Benin 5
GR - Grecia 5
MA - Marocco 5
ID - Indonesia 4
KE - Kenya 4
PY - Paraguay 4
TN - Tunisia 4
AZ - Azerbaigian 3
CL - Cile 3
EU - Europa 3
IL - Israele 3
PK - Pakistan 3
SA - Arabia Saudita 3
AT - Austria 2
BG - Bulgaria 2
EG - Egitto 2
KG - Kirghizistan 2
KZ - Kazakistan 2
RO - Romania 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LT - Lituania 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.271
Salva come PNG Salva come JPEG
Città #
Dallas 508
Santa Clara 483
Singapore 387
Chandler 373
Chicago 306
Dublin 290
Abidjan 209
Ashburn 163
Jacksonville 160
Civitanova Marche 145
Catania 126
Boardman 123
Hefei 104
Beijing 99
Los Angeles 86
Andover 75
Cambridge 75
Lawrence 75
Grafing 73
Nanjing 71
Dakar 58
Rotterdam 55
Seoul 53
Toronto 53
Wingene 50
Houston 41
Quintano 41
Wilmington 40
Dong Ket 39
Des Moines 38
Brussels 31
San Mateo 30
Agrigento 29
New York 26
The Dalles 26
Ho Chi Minh City 24
São Paulo 24
Columbus 23
Hanoi 21
Nanchang 21
Paternò 21
Council Bluffs 20
Hebei 19
Munich 19
Buffalo 17
Kochi 17
Tokyo 16
London 15
Ottawa 15
Saint Petersburg 15
Bremen 14
Jiaxing 14
Redondo Beach 12
Shenyang 12
Tianjin 12
Changsha 11
Nijmegen 11
Stockholm 11
Chennai 10
Denver 10
Warsaw 10
Atlanta 9
Boston 9
Izegem 9
Manchester 9
Mumbai 9
Rio de Janeiro 9
Seattle 9
Abuja 8
Amsterdam 8
Guangzhou 8
Pune 8
San Francisco 8
Ardabil 7
Bari 7
Brooklyn 7
Gravina di Catania 7
Hong Kong 7
Jinan 7
New Delhi 7
Poplar 7
Zhengzhou 7
Brasília 6
Brno 6
Knoxville 6
Kunming 6
Redmond 6
Redwood City 6
Reggio Emilia 6
Valledolmo 6
Ankara 5
Cotonou 5
Düsseldorf 5
Edinburgh 5
Falls Church 5
Johannesburg 5
Lappeenranta 5
Leawood 5
Messina 5
Moscow 5
Totale 5.219
Salva come PNG Salva come JPEG
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 214
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 157
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 140
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 132
Comparative proteomic analysis of insulin receptor isoform A and B signaling 126
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 124
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 121
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 117
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation 117
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 114
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 113
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 111
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 109
BRAF(V600E) mutation and the biology of papillary thyroid cancer 108
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 107
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 106
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 105
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 103
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 102
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 99
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 98
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 96
Abstract 4612: In breast cancer cells IGF-I induces upregulation of DDR1 by suppressing miR-199a-5p via the PI3K/Akt pathway 96
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 95
Insulin receptor isoforms in physiology and disease: An updated view 95
Comment on “Shiatsu as an Adjuvant Therapy for Depression in Patients With Alzheimer’s Disease: A Pilot Study” 95
PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis 94
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 94
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 93
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 92
Insulin resistance: Any role in the changing epidemiology of thyroid cancer? 91
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 91
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 90
p73 tumor-suppressor activity is impaired in human thyroid cancer 87
The IGF system in thyroid cancer:new concepts 86
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 84
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 83
p53 family proteins in thyroid cancer 82
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 82
Editorial: Early diagnoses and treatments of uncommon breast cancers 80
Metabolic alterations of thyroid cancer as potential therapeutic targets 80
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 80
The p53-homologue p63 may promote thyroid cancer progression 79
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 79
Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study 79
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 79
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 78
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 76
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 75
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 74
The emerging role of insulin receptor isoforms in thyroid cancer: Clinical implications and new perspectives 74
Insulin receptor isoforms in cancer 74
Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection 73
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 72
Editorial: Resistance to Endocrine Therapies in Cancer 72
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 71
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 70
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 69
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 69
Thyrospheres an in vitro model for human thyroid carcinogenesis 69
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 69
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 69
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 67
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 67
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 66
COVID-19 and Diabetes: The Importance of Controlling RAGE 66
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 65
Type 3 deiodinase: Role in cancer growth, stemness, and metabolism 65
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 63
Role of BRAF(V600) mutation in the resistance to gefinitib of thyroid cancer cells. 61
Long-acting insulin analogs and cancer 60
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 59
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 59
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 58
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 57
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 57
The expression of PTEN tumor suppressor is down regulated by the dominant negative p73 isoform ΔNp73 in thyroid cancer cells 56
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 56
EGFR INHIBITION ENHANCES THE SENSITIVITY OF POORLY DIFFERENTIATED THYROID CANCER CELLS TO CHEMOTHERAPY 56
Manuale di endocrinologia geriatrica 55
Editorial: A year in review: discussions in cancer endocrinology 53
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 52
REACTIVATION OF P53 MUTANTS BY SMALL COMPOUNDS MAY REPRESENT AN ADJUVANT THERAPY OF POORLY DIFFERENTIATED THYROID CANCER 52
Metyrapone restores nocturnal cortisol profile and impaired post-dexamethasone suppression in mild autonomous cortisol secretion due to bilateral adrenal incidentaloma 51
P63 EXPRESSION AND FUNCTION IN THYROID CANCER 51
REGULATION OF mirRNAS BY p53 FAMILIY MEMBERS IN THYROID CANCER CELLS 51
Short-term adverse affects of anticancer drugs in type 2 diabetes patients. 50
Identification of Thyroid Cancer Stem Cells 50
Levels of histone acetylation in thyroid tumors 47
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 41
Totale 7.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021371 0 0 0 0 98 7 43 12 105 9 57 40
2021/2022555 49 91 15 7 82 3 82 29 42 0 17 138
2022/20231.252 82 43 36 155 124 182 34 230 269 24 40 33
2023/2024639 22 124 24 53 19 134 7 67 13 26 87 63
2024/20252.285 109 434 103 216 419 233 73 74 171 143 177 133
2025/20261.734 240 217 635 308 334 0 0 0 0 0 0 0
Totale 7.450